EIF1B
gene geneOn this page
Also known as GC20
Summary
EIF1B (eukaryotic translation initiation factor 1B, HGNC:30792) is a protein-coding gene on chromosome 3p22.1, encoding Eukaryotic translation initiation factor 1b (O60739). Probably involved in translation.
Enables RNA binding activity. Predicted to be involved in regulation of translational initiation. Predicted to be part of eukaryotic 43S preinitiation complex.
Source: NCBI Gene 10289 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 11 total
- MANE Select transcript:
NM_005875
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30792 |
| Approved symbol | EIF1B |
| Name | eukaryotic translation initiation factor 1B |
| Location | 3p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | GC20 |
| Ensembl gene | ENSG00000114784 |
| Ensembl biotype | protein_coding |
| Entrez | 10289 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 retained_intron, 1 protein_coding
ENST00000232905, ENST00000462088, ENST00000487151, ENST00000488260
RefSeq mRNA: 1 — MANE Select: NM_005875
NM_005875
CCDS: CCDS2690
Canonical transcript exons
ENST00000232905 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000825747 | 40311970 | 40312424 |
| ENSE00001030073 | 40309707 | 40309972 |
| ENSE00001167219 | 40311470 | 40311571 |
| ENSE00003538070 | 40310893 | 40311056 |
Expression profiles
Bgee: expression breadth ubiquitous, 294 present calls, max score 99.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 174.0310 / max 3842.7949, expressed in 1827 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36173 | 108.2803 | 1821 |
| 36175 | 26.1850 | 1810 |
| 36176 | 22.2835 | 1814 |
| 36174 | 17.0001 | 1791 |
| 36177 | 0.2821 | 114 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| heart right ventricle | UBERON:0002080 | 99.31 | gold quality |
| adult organism | UBERON:0007023 | 99.15 | gold quality |
| cardiac ventricle | UBERON:0002082 | 99.13 | gold quality |
| heart left ventricle | UBERON:0002084 | 99.13 | gold quality |
| pons | UBERON:0000988 | 99.11 | gold quality |
| myocardium | UBERON:0002349 | 99.09 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 99.09 | gold quality |
| cardiac atrium | UBERON:0002081 | 99.05 | gold quality |
| right atrium auricular region | UBERON:0006631 | 99.05 | gold quality |
| endothelial cell | CL:0000115 | 98.95 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 98.86 | gold quality |
| heart | UBERON:0000948 | 98.81 | gold quality |
| apex of heart | UBERON:0002098 | 98.81 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 98.81 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 98.76 | gold quality |
| vena cava | UBERON:0004087 | 98.75 | gold quality |
| ganglionic eminence | UBERON:0004023 | 98.69 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 98.69 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 98.68 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 98.64 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 98.62 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 98.60 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 98.59 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 98.52 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 98.45 | gold quality |
| biceps brachii | UBERON:0001507 | 98.42 | gold quality |
| cortical plate | UBERON:0005343 | 98.42 | gold quality |
| cartilage tissue | UBERON:0002418 | 98.40 | gold quality |
| postcentral gyrus | UBERON:0002581 | 98.37 | gold quality |
| ventricular zone | UBERON:0003053 | 98.37 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9221 | yes | 11.33 |
| E-MTAB-10042 | yes | 5.99 |
| E-MTAB-8410 | yes | 3.90 |
| E-HCAD-5 | no | 7.70 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
49 targeting EIF1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4802-3P | 99.72 | 70.13 | 1273 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-548U | 99.65 | 67.78 | 1463 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-6513-3P | 99.59 | 69.77 | 1102 |
| HSA-MIR-5571-5P | 99.49 | 66.99 | 1764 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-3978 | 99.24 | 68.39 | 2201 |
| HSA-MIR-223-5P | 99.24 | 68.82 | 1206 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | eif1b | ENSDARG00000029445 |
| mus_musculus | Eif1b | ENSMUSG00000006941 |
| rattus_norvegicus | Eif1b | ENSRNOG00000018848 |
| caenorhabditis_elegans | WBGENE00020868 |
Paralogs (1): EIF1 (ENSG00000173812)
Protein
Protein identifiers
Eukaryotic translation initiation factor 1b — O60739 (reviewed: O60739)
Alternative names: Protein translation factor SUI1 homolog GC20
All UniProt accessions (2): O60739, Q6FG85
UniProt curated annotations — full annotation on UniProt →
Function. Probably involved in translation.
Similarity. Belongs to the SUI1 family.
RefSeq proteins (1): NP_005866* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001950 | SUI1 | Domain |
| IPR005874 | SUI1_euk | Family |
| IPR036877 | SUI1_dom_sf | Homologous_superfamily |
Pfam: PF01253
UniProt features (6 total): modified residue 2, sequence conflict 2, initiator methionine 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60739-F1 | 80.41 | 0.29 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 2, 9
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 157 (showing top):
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10, ENK_UV_RESPONSE_KERATINOCYTE_UP, GOBP_TRANSLATIONAL_INITIATION, GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GROSS_HYPOXIA_VIA_HIF1A_DN, chr3p22, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, HU_GENOTOXIC_DAMAGE_24HR, ACEVEDO_LIVER_CANCER_UP, LEE_CALORIE_RESTRICTION_MUSCLE_DN, ATGTTTC_MIR494, GOBP_REGULATION_OF_TRANSLATION, GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION
GO Biological Process (5): regulation of translational initiation (GO:0006446), translation (GO:0006412), translational initiation (GO:0006413), regulation of gene expression (GO:0010468), regulation of primary metabolic process (GO:0080090)
GO Molecular Function (4): RNA binding (GO:0003723), translation initiation factor activity (GO:0003743), ribosomal small subunit binding (GO:0043024), protein binding (GO:0005515)
GO Cellular Component (1): eukaryotic 43S preinitiation complex (GO:0016282)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| translational initiation | 3 |
| regulation of translation | 1 |
| peptidyltransferase activity | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| formation of translation initiation ternary complex | 1 |
| translation | 1 |
| metabolic process | 1 |
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| regulation of metabolic process | 1 |
| primary metabolic process | 1 |
| nucleic acid binding | 1 |
| translation factor activity | 1 |
| ribosome binding | 1 |
| binding | 1 |
| cytosolic small ribosomal subunit | 1 |
| cytosolic translation preinitiation complex | 1 |
Protein interactions and networks
STRING
2073 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EIF1B | ATP5IF1 | Q9UII2 | 609 |
| EIF1B | LMCD1 | Q9NZU5 | 571 |
| EIF1B | EIF3K | Q9UBQ5 | 484 |
| EIF1B | EIF2S2 | P20042 | 480 |
| EIF1B | MRPS21 | P82921 | 480 |
| EIF1B | EIF5B | O60841 | 454 |
| EIF1B | EIF5 | P55010 | 453 |
| EIF1B | LTA4H | P09960 | 453 |
| EIF1B | ECM1 | Q16610 | 453 |
| EIF1B | RBM23 | Q86U06 | 448 |
| EIF1B | HTR2B | P41595 | 447 |
| EIF1B | RAB31 | Q13636 | 446 |
| EIF1B | EIF2S1 | P05198 | 440 |
| EIF1B | ROBO1 | Q9Y6N7 | 435 |
| EIF1B | EIF3J | O75822 | 430 |
IntAct
193 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UCHL1 | EIF1B | psi-mi:“MI:0915”(physical association) | 0.680 |
| EIF1B | FUS | psi-mi:“MI:0915”(physical association) | 0.680 |
| EIF1B | DVL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EIF1B | SPG21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EIF1B | psi-mi:“MI:0915”(physical association) | 0.370 | |
| EIF1B | iglC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RHOB | EIF1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| PEX19 | EIF1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| ATXN1 | EIF1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| EIF1B | DVL2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CD74 | psi-mi:“MI:0914”(association) | 0.350 | |
| DDX60 | G6PD | psi-mi:“MI:0914”(association) | 0.350 |
| EIF3B | EIF3CL | psi-mi:“MI:0914”(association) | 0.350 |
| NPM1 | RPS3A | psi-mi:“MI:0914”(association) | 0.350 |
| PSPC1 | MCRIP1 | psi-mi:“MI:0914”(association) | 0.350 |
| RPS16 | MCRIP1 | psi-mi:“MI:0914”(association) | 0.350 |
| EIF1B | POTEI | psi-mi:“MI:0914”(association) | 0.350 |
| NPPB | ACOT7 | psi-mi:“MI:0914”(association) | 0.350 |
| EIF1B | EIF3E | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1B | EIF3A | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1B | EIF3K | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1B | ACTR3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1B | VEPH1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1B | EIF3H | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1B | EIF3G | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (59): TRIM38 (Two-hybrid), EIF1B (Co-fractionation), EIF1B (Co-fractionation), EIF2D (Co-fractionation), EIF3G (Co-fractionation), TJP2 (Co-fractionation), DVL2 (Two-hybrid), EIF3A (Affinity Capture-MS), EIF3L (Affinity Capture-MS), EIF3M (Affinity Capture-MS), EIF3F (Affinity Capture-MS), EIF3D (Affinity Capture-MS), EIF3E (Affinity Capture-MS), ACTR3 (Affinity Capture-MS), RPS11 (Affinity Capture-MS)
ESM2 similar proteins: A0A324, A1XQR9, A4FUI2, A5JSS2, A6MZM2, G1SHQ2, O09167, O14602, O35900, O60739, P20280, P25800, P41567, P46778, P47813, P48024, P49666, P51971, P61220, P62303, P62304, P62305, P62308, P62309, Q09028, Q0D5W6, Q0P5B3, Q2KIA3, Q3B8H4, Q3ZBL0, Q4R4X9, Q503U0, Q5E938, Q5RA42, Q5RBW7, Q5RFF4, Q60872, Q60972, Q6GVM3, Q6QN05
Diamond homologs: A0B635, A0RWW9, A2BIX0, A2SQ91, A3CX23, A4FWB4, A4YIU6, A6VGZ2, A7I9K6, A8AC05, A9A389, A9A9Q7, B0R868, B6YSM1, B8GDE2, B9LR02, C5A278, O26118, O29348, O60739, P08245, P0A2G7, P0A2G8, P14021, P41567, P42678, P45116, P48024, P51971, P58193, P61220, P79060, Q12UF1, Q2FTC8, Q2NFW4, Q3IU96, Q46F27, Q4JAE7, Q4R4X9, Q55397
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| EIF1B | “up-regulates activity” | “40S cytosolic small ribosomal subunit” | relocalization |
| EIF1B | “down-regulates activity” | “60S cytosolic large ribosomal subunit” |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 176 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Formation of the ternary complex, and subsequently, the 43S complex | 25 | 36.4× | 8e-32 |
| Translation initiation complex formation | 26 | 33.4× | 7e-32 |
| Ribosomal scanning and start codon recognition | 26 | 33.4× | 7e-32 |
| Eukaryotic Translation Elongation | 13 | 24.5× | 1e-13 |
| Formation of a pool of free 40S subunits | 32 | 24.2× | 5e-34 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 35 | 23.9× | 7e-37 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 35 | 23.7× | 7e-37 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | 6 | 23.1× | 2e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| formation of cytoplasmic translation initiation complex | 12 | 77.9× | 1e-19 |
| translational initiation | 17 | 35.2× | 8e-20 |
| cytoplasmic translation | 21 | 22.5× | 6e-20 |
| regulation of translational initiation | 5 | 13.5× | 4e-03 |
| translation | 22 | 13.1× | 4e-16 |
| ribosomal small subunit biogenesis | 8 | 10.5× | 2e-04 |
| positive regulation of translation | 6 | 7.9× | 8e-03 |
| protein folding | 9 | 5.4× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
374 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:40310881:A:AG | acceptor_gain | 1.0000 |
| 3:40310882:T:G | acceptor_gain | 1.0000 |
| 3:40310885:A:AG | acceptor_gain | 1.0000 |
| 3:40310886:T:G | acceptor_gain | 1.0000 |
| 3:40310891:A:AG | acceptor_gain | 1.0000 |
| 3:40310892:G:GG | acceptor_gain | 1.0000 |
| 3:40311456:AT:A | acceptor_gain | 1.0000 |
| 3:40311457:T:TA | acceptor_gain | 1.0000 |
| 3:40311460:A:AG | acceptor_gain | 1.0000 |
| 3:40311461:C:G | acceptor_gain | 1.0000 |
| 3:40311464:TTCCA:T | acceptor_loss | 1.0000 |
| 3:40311465:TCCAG:T | acceptor_loss | 1.0000 |
| 3:40311466:CCAG:C | acceptor_loss | 1.0000 |
| 3:40311467:CAGAA:C | acceptor_loss | 1.0000 |
| 3:40311468:A:AG | acceptor_gain | 1.0000 |
| 3:40311468:AGAAA:A | acceptor_loss | 1.0000 |
| 3:40311469:G:GT | acceptor_gain | 1.0000 |
| 3:40311469:GA:G | acceptor_gain | 1.0000 |
| 3:40311469:GAA:G | acceptor_gain | 1.0000 |
| 3:40311469:GAAA:G | acceptor_gain | 1.0000 |
| 3:40311469:GAAAT:G | acceptor_gain | 1.0000 |
| 3:40311568:GGAG:G | donor_gain | 1.0000 |
| 3:40311569:GAG:G | donor_gain | 1.0000 |
| 3:40311569:GAGG:G | donor_gain | 1.0000 |
| 3:40311570:AGGT:A | donor_loss | 1.0000 |
| 3:40311571:GGTG:G | donor_loss | 1.0000 |
| 3:40311572:G:GG | donor_gain | 1.0000 |
| 3:40311573:T:G | donor_loss | 1.0000 |
| 3:40310885:ATTC:A | acceptor_gain | 0.9900 |
| 3:40310888:C:A | acceptor_gain | 0.9900 |
AlphaMissense
751 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:40310962:G:C | R34T | 1.000 |
| 3:40310963:A:C | R34S | 1.000 |
| 3:40310963:A:T | R34S | 1.000 |
| 3:40310972:A:C | Q37H | 1.000 |
| 3:40310972:A:T | Q37H | 1.000 |
| 3:40310974:G:C | R38P | 1.000 |
| 3:40310980:G:A | G40D | 1.000 |
| 3:40310983:G:C | R41T | 1.000 |
| 3:40310983:G:T | R41I | 1.000 |
| 3:40310984:A:C | R41S | 1.000 |
| 3:40310984:A:T | R41S | 1.000 |
| 3:40310985:A:G | K42E | 1.000 |
| 3:40310987:G:C | K42N | 1.000 |
| 3:40310987:G:T | K42N | 1.000 |
| 3:40310992:T:C | L44P | 1.000 |
| 3:40311001:T:A | V47D | 1.000 |
| 3:40311051:A:G | K64E | 1.000 |
| 3:40311053:A:C | K64N | 1.000 |
| 3:40311053:A:T | K64N | 1.000 |
| 3:40311480:G:A | C69Y | 1.000 |
| 3:40311481:T:G | C69W | 1.000 |
| 3:40311485:G:C | G71R | 1.000 |
| 3:40311486:G:A | G71D | 1.000 |
| 3:40311528:T:C | L85P | 1.000 |
| 3:40311533:G:A | G87S | 1.000 |
| 3:40311533:G:C | G87R | 1.000 |
| 3:40311533:G:T | G87C | 1.000 |
| 3:40311534:G:A | G87D | 1.000 |
| 3:40311534:G:T | G87V | 1.000 |
| 3:40311536:G:C | D88H | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1001009956 (3:40308614 T>C), RS1001519270 (3:40312166 T>C), RS1001629319 (3:40311308 C>A,T), RS1002083067 (3:40311669 G>A,C,T), RS1002086741 (3:40310114 C>A,T), RS1003351369 (3:40310201 C>A,G,T), RS1003710292 (3:40309967 C>T), RS1004026271 (3:40307998 A>G), RS1004975924 (3:40309214 C>G), RS1004980940 (3:40311738 T>C), RS1005273038 (3:40311290 T>C), RS1005338817 (3:40308517 A>G), RS1005438045 (3:40309448 T>C), RS1005557999 (3:40308195 A>G), RS1006137873 (3:40311824 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_421 | Refractive error | 3.000000e-27 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Cadmium | decreases expression, increases abundance, increases expression | 2 |
| Tretinoin | increases expression | 2 |
| Valproic Acid | increases expression, decreases expression | 2 |
| Cadmium Chloride | increases abundance, increases expression, decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| chloropicrin | affects expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| abrine | increases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | increases expression | 1 |
| eprenetapopt | affects expression, affects reaction | 1 |
| Air Pollutants, Occupational | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Caffeine | affects phosphorylation | 1 |
| Cisplatin | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Nickel | increases expression | 1 |
| Phenobarbital | affects expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Rotenone | decreases expression | 1 |
| Selenium | decreases expression | 1 |
| Theophylline | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SL60 | HAP1 EIF1B (-) 1 | Cancer cell line | Male |
| CVCL_SL61 | HAP1 EIF1B (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.